CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $24.58M, above the global median of $16.24M
- PositionOperating margin is 50.3%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations9 currently firing — 9
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.69%
Annual Rate
JPY 41.00Paid unknown
Payout Ratio
42.1%Sustainable
Next Ex-Dividend
Mar 30, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
62.64BJPY395.36M · vs all stocks (USD)
Trailing P/E
15.67xvs Medical Instruments & Supplies peers
Revenue (TTM)
11.53BJPY72.77M · vs all stocks (USD)
Profit Margin
36.05%vs Medical Instruments & Supplies peers
52-Week Change
1.37%vs all stocks
Forward Annual Dividend Yield
2.69%vs all stocks
Market Capitalization
62.64BJPY395.36M · vs all stocks (USD)
Enterprise Value
46.85BJPY295.69M · vs all stocks (USD)
Trailing P/E
15.67xvs Medical Instruments & Supplies peers
Forward P/E
13.08xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
5.15xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.99xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.06xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
7.63xvs Medical Instruments & Supplies peers
Profit Margin
36.05%vs Medical Instruments & Supplies peers
Operating Margin
50.31%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
19.58%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
22.33%vs Medical Instruments & Supplies peers
Revenue (TTM)
11.53BJPY72.77M · vs all stocks (USD)
Revenue per Share (TTM)
288.25JPYUpdated Aug 20, 2026Quarterly Revenue Growth
24.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
7.53BJPY47.54M · vs all stocks (USD)
EBITDA (TTM)
6.14BJPY38.78M · vs all stocks (USD)
Net Income (TTM)
4.16BJPY26.24M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
35.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
3.87BJPY24.43M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.90BJPY24.58M · vs all stocks (USD)
Forward Annual Dividend Rate
41.00JPYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.69%vs all stocks
Trailing Annual Dividend Rate
41.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.69%vs all stocks
Payout Ratio
42.10%vs Medical Instruments & Supplies peers
Revenue
10.95BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
3.73BJPYFY2026 · Mar 31, 2026Gross Profit
7.21BJPYFY2026 · Mar 31, 2026Operating Income
5.86BJPY36.98M · vs all stocks (USD)
Pre-tax Income
5.90BJPYFY2026 · Mar 31, 2026Income Tax Expense
2.01BJPYFY2026 · Mar 31, 2026Net Income
3.90BJPYFY2026 · Mar 31, 2026EBIT
5.91BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
6.14BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
29.00MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
1.00MJPYFY2026 · Mar 31, 2026EPS (Basic)
97.38JPYFY2026 · Mar 31, 2026EPS (Diluted)
97.38JPYFY2026 · Mar 31, 2026Basic Shares Outstanding
40.00MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
40.00MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
5.59BJPYFY2026 · Mar 31, 2026Free Cash Flow
5.35BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
13.41BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
5.90BJPYFY2026 · Mar 31, 2026Other Non-cash Items
-1.00MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-102.00MJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-209.00MJPYFY2026 · Mar 31, 2026Capital Expenditures
-239.00MJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
0.00JPYFY2026 · Mar 31, 2026Sale of Investments
0.00JPYFY2026 · Mar 31, 2026Other Investing Activity
2.00MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-237.00MJPYFY2026 · Mar 31, 2026Common Dividends Paid
-1.64BJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
-1.64BJPYFY2026 · Mar 31, 2026Shares Outstanding
40.00MSharesUpdated Aug 20, 2026% Held by Insiders
58.75%vs all stocks
% Held by Institutions
26.59%vs all stocks
Total Cash (MRQ)
12.51BJPY78.97M · vs all stocks (USD)
Total Cash per Share (MRQ)
312.80JPYUpdated Aug 20, 2026Total Debt (MRQ)
0.00JPYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
15.00xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
496.77JPYUpdated Aug 20, 2026Total Assets
22.00BJPY138.83M · vs all stocks (USD)
Total Current Assets
17.15BJPYFY2026 · Mar 31, 2026Total Liabilities
1.49BJPYFY2026 · Mar 31, 2026Total Non-current Assets
4.85BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
62.00MJPYFY2026 · Mar 31, 2026Total Current Liabilities
1.43BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
13.41BJPYFY2026 · Mar 31, 2026Accounts Receivable
1.56BJPYFY2026 · Mar 31, 2026Inventory
2.00BJPYFY2026 · Mar 31, 2026Accounts Payable
187.00MJPYFY2026 · Mar 31, 2026Other Current Liabilities
218.00MJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
62.00MJPYFY2026 · Mar 31, 2026Common Stock (Book)
10.00MJPYFY2026 · Mar 31, 2026Retained Earnings
20.49BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
20.50BJPY129.41M · vs all stocks (USD)
52-Week Low
1.16KJPYUpdated Aug 20, 202652-Week High
1.70KJPYUpdated Aug 20, 202652-Week Change
1.37%vs all stocks
50-Day MA
1.34KJPYUpdated Aug 20, 2026200-Day MA
1.40KJPYUpdated Aug 20, 2026Avg 10-Day Volume
144.41KSharesUpdated Aug 20, 2026Avg 30-Day Volume
126.85KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
94.68JPYUpdated Aug 20, 20269 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Revenue Growth With Elevated Margin
Revenue up in each of five years, while its operating margin stays high.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 50.3%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.50Industry median: 0.12Industry P95: 0.27Peers compared: 65.00
Profit margin is 36.1%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: 0.36Industry median: 0.08Industry P95: 0.25Peers compared: 65.00
Return on equity is 22.3%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: 0.22Industry median: 0.06Industry P95: 0.21Peers compared: 65.00
Return on assets is 19.6%, higher than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: 0.20Industry median: 0.04Industry P95: 0.13Peers compared: 65.00
Current ratio is 15×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 15.00Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Financial Health
High earnings qualityNotable
Earnings Quality Score: 1.19
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $24.58M, above the global median of $16.24MNotable
Levered free cash flow (USD): 24,583,682Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Qinhuangdao Tianqin Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangnan Yifan Motor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Wuxi Hodgen Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
IC Enterra Yenilenebilir Enerji A.Ş.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hefei Changqing Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Seoul Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen Moso Power Supply Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Karon Eco-Valve Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
F.W. Thorpe Public Limited Company
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Kona I Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Insource Co., Ltd.
9 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRevenue Growth With Elevated MarginThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year FCF With Growth And Margin
Aryt Industries Ltd.
9 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRevenue Growth With Elevated MarginThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year FCF With Growth And Margin
United States Lime & Minerals Inc.
9 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRevenue Growth With Elevated MarginThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsMulti-Year FCF With Growth And Margin